Skip to main content

Table 1 Clinical characteristics of the 17 patients at the time of VA-ECMO implantation

From: Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation

Variable Value
Age, yr, median (range) 51 (18–70)
Male 6 (35)
Body mass index, kg/m2 29 (20–35)
McCabe and Jackson score ≥2 3 (18)
Charlson score ≥2 5 (29)
SAPS II 78 (45–95)
SOFA score 12 (8–16)
Predisposing factors for venous thromboembolism 11 (65)
 Postoperative status 4
 Immobility due to sitting 2
 Oral contraception 1
 Previous venous thromboembolism 3
 Postpartum period 3
 Hospitalization for HF or AF (within previous 3 months) 2
ECMO implantation by Mobile ECMO Unit 7 (41)
Femoral–femoral VA-ECMO 16 (94)
Pre-ECMO cardiac arrest 15 (88)
 No-flow time, min 0 (0–11)
 Low-flow time, min 30 (10–85)
 ECMO during cardiopulmonary resuscitation 7 (41)
Pre-ECMO systolic blood pressure, mmHg 55 (0–130)
Pre-ECMO mean blood pressure, mmHg 42 (0–106)
Pre-ECMO heart rate, bpm 95 (0–177)
Pre-ECMO inotrope score, μg/kg/min 100 (1.8–760)
pH 6.99 (6.54–7.37)
Blood lactate, mmol/L 13.3 (4.2–19.0)
Bicarbonate, mmol/L 12 (3–25)
Troponin I, μg/mL 2.2 (0.1–23.7)
PaO2/FiO2 ratio 198 (32–674)
PaCO2, mmHg 48 (17–102)
Bilirubin, mmol/L 8 (6–124)
Prothrombin activity, % 34 (10–72)
Pre-ECMO cardiac echocardiography 17 (100)
 RV dilation 17 (100)
 Pulmonary artery thrombus 3 (18)
 LVEF, % 40 (5–60)
Pre-ECMO chest CT scan 12 (71)
 Proximal PE 10 (59)
 Pulmonary infarction 3 (18)
RV/LV dimensions ratio 1.3 (0.7–1.6)
Pre-ECMO systemic fibrinolytic therapy 8 (47)
Pre-ECMO surgical thrombectomy 2 (12)
Pre-ECMO catheter-directed thromboaspiration 1 (6)
  1. Categorical variables are expressed as n (%) and continuous variables as median (range), unless stated otherwise
  2. VA-ECMO venoarterial-extracorporeal membrane oxygenation, SAPS II Simplified Acute Physiology Score II, SOFA Sequential Organ Failure Assessment, AF atrial fibrillation, HF heart failure, RV right ventricular, LVEF left ventricular ejection fraction